Komipharm International Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was KRW 255.97 million compared to KRW 271.02 million a year ago. Net income was KRW 768.15 million compared to net loss of KRW 826.55 million a year ago.

Basic earnings per share from continuing operations was KRW 11 compared to basic loss per share from continuing operations of KRW 12 a year ago. Basic earnings per share was KRW 11 compared to basic loss per share of KRW 12 a year ago.